| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals, Inc. (SNDX) has 3 insiders with recent SEC Form 4 filings, including 2 buys and 15 sells. SNDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.8K | $9.39M | -6,847 | |
| CFO | 139.3K | $2.70M | -1,177 | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Egros Fabrice | Director | Sale+OE | 14,030 | $18.03 | $252,993.17 | -30.5% | -7.1% | +23.9% | |
| Oct 26, 2021 | Metzger Michael A52 | President And COO | Sale+OE | 61,000 | $19.15 | $1,168,159.58 | -63.3% | -12.1% | +21.3% | |
| Sep 27, 2021 | Metzger Michael A52 | President And COO | Sale+OE | 24,437 | $19.51 | $476,831.85 | -58.1% | +11.1% | +18.2% | |
| Sep 22, 2021 | Metzger Michael A52 | President And COO | Sale+OE | 36,563 | $19.22 | $702,860.66 | -40.8% | +12.9% | +21.2% | |
| Sep 20, 2021 | Morrison Briggs61 | Chief Executive Officer | Sale+OE | 70,312 | $20.07 | $1,411,017.82 | -42.1% | +12.4% | +25.9% | |
| Sep 14, 2021 | Metzger Michael A52 | President And COO | Sale+OE | 61,000 | $19.12 | $1,166,032.97 | -63.3% | -4.7% | +25.6% | |
| Aug 18, 2021 | Egros Fabrice | Director | Sale+OE | 15,635 | $15.75 | $246,327.86 | -49.4% | +17.2% | +54.7% | |
| May 18, 2021 | Egros Fabrice | Director | Sale+OE | 13,609 | $18.65 | $253,783.35 | -28.8% | -14.8% | -26.1% | |
| Apr 26, 2021 | Meyers Michael L. | SVP, Chief Medical Officer | Buy | 500 | $15.46 | $7,730.00 | +3.3% | -10.7% | +2.0% | |
| Apr 22, 2021 | Podlesak Dennis62 | Director | Buy | 13,967 | $14.11 | $197,077.16 | +47.6% | +7.5% | +15.7% |